<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bao G</submitter><funding>Yunnan Provincial Fund for High-Level Reserve Talents in Health Science</funding><funding>Yunnan Applied Basic Research Projects-Kunming Medical University Union Foundation</funding><funding>National Natural Science Foundation of China</funding><pagination>279</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12366207</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Disruption in bile duct barrier function contributes to hepatocyte toxicity in ischemia-reperfusion injury, often leading to surgical complications in liver resection, transplantation, and hemorrhagic shock. However, the underlying mechanisms remain incompletely understood.&lt;h4>Methods&lt;/h4>Transcriptomic and proteomic analyses were conducted to examine tryptophan (Trp) metabolism in a Pringle maneuver-induced bile duct injury rat model; Hypoxia/Reoxygenation (H/R) was used to establish an in vitro cholangiocyte injury model. Cholangiocyte injury was assessed via hematoxylin and eosin (H&amp;E) staining, Ki67/myeloperoxidase (MPO) immunohistochemistry, transmission electron microscopy (TEM), and TUNEL/CK19 co-staining. Tight junction integrity was evaluated by measuring transe</pubmed_abstract><journal>Molecular medicine (Cambridge, Mass.)</journal><pubmed_title>Kynu inhibition mitigates bile duct ischemic injury by rewiring tryptophan metabolism to restore tight junction integrity.</pubmed_title><pmcid>PMC12366207</pmcid><funding_grant_id>202001AY070001-040</funding_grant_id><funding_grant_id>81860121</funding_grant_id><funding_grant_id>H-2018068</funding_grant_id><pubmed_authors>Bao G</pubmed_authors><pubmed_authors>Bi P</pubmed_authors><pubmed_authors>Yang B</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Ye Z</pubmed_authors><pubmed_authors>Luo D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Kynu inhibition mitigates bile duct ischemic injury by rewiring tryptophan metabolism to restore tight junction integrity.</name><description>&lt;h4>Background&lt;/h4>Disruption in bile duct barrier function contributes to hepatocyte toxicity in ischemia-reperfusion injury, often leading to surgical complications in liver resection, transplantation, and hemorrhagic shock. However, the underlying mechanisms remain incompletely understood.&lt;h4>Methods&lt;/h4>Transcriptomic and proteomic analyses were conducted to examine tryptophan (Trp) metabolism in a Pringle maneuver-induced bile duct injury rat model; Hypoxia/Reoxygenation (H/R) was used to establish an in vitro cholangiocyte injury model. Cholangiocyte injury was assessed via hematoxylin and eosin (H&amp;E) staining, Ki67/myeloperoxidase (MPO) immunohistochemistry, transmission electron microscopy (TEM), and TUNEL/CK19 co-staining. Tight junction integrity was evaluated by measuring transe</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-05T18:04:56.18Z</modification><creation>2026-04-07T21:43:47.947Z</creation></dates><accession>S-EPMC12366207</accession><cross_references><pubmed>40830424</pubmed><doi>10.1186/s10020-025-01310-6</doi></cross_references></HashMap>